A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II)-Reference-Cited by-同舟云学术

A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II)

Published:2018-09 Issue: Volume:101 Page:220-228
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Nishikawa Kazuhiro^ORCID,Tsuburaya Akira,Yoshikawa Takaki,Kobayashi Michiya,Kawada Junji,Fukushima Ryoji,Matsui Takanori,Tanabe Kazuaki,Yamaguchi Kazuya,Yoshino Shigefumi,Takahashi Masazumi,Hirabayashi Naoki,Sato Seiji,Nemoto Hiroshi,Rino Yasushi,Nakajima Junta,Aoyama Toru^ORCID,Miyagi Yohei,Oriuchi Noboru,Yamaguchi Kensei,Miyashita Yumi,Morita Satoshi,Sakamoto Junichi

Funder

Epidemiological and Clinical Research Information Network (ECRIN)

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Canc,2015

2. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data;Wagner;J Clin Oncol,2006

3. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group;Van Cutsem;J Clin Oncol,2006

4. Capecitabine and oxaliplatin for advanced esophagogastric cancer;Cunnigham;N Engl J Med,2008

5. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study;Boku;Lancet Oncol,2009

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer;International Journal of Clinical Oncology;2023-08-27

2. Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer;2023-07-07

3. Application and progress of palliative therapy in advanced gastric carcinomas;Frontiers in Oncology;2023-03-09

4. Histology Classification Highlights Differences in Efficacy of S-1 versus Capecitabine, in Combination with Cisplatin, for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer with Measurable Disease;Cancers;2022-11-18

5. Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial;Anticancer Research;2022-03-28